rs374518328
Variant summary
Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP6_ModerateBS2
The NM_004304.5(ALK):c.3172+10_3172+11delCA variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000131 in 1,608,216 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely benign (★).
Frequency
 Genomes: 𝑓 0.000039   (  0   hom.,  cov: 32) 
 Exomes 𝑓:  0.000010   (  0   hom.  ) 
Consequence
 ALK
NM_004304.5 intron
NM_004304.5 intron
Scores
 Not classified 
Clinical Significance
Conservation
 PhyloP100:  0.450  
Publications
0 publications found 
Genes affected
 ALK  (HGNC:427):  (ALK receptor tyrosine kinase) This gene encodes a receptor tyrosine kinase, which belongs to the insulin receptor superfamily. This protein comprises an extracellular domain, an hydrophobic stretch corresponding to a single pass transmembrane region, and an intracellular kinase domain. It plays an important role in the development of the brain and exerts its effects on specific neurons in the nervous system. This gene has been found to be rearranged, mutated, or amplified in a series of tumours including anaplastic large cell lymphomas, neuroblastoma, and non-small cell lung cancer. The chromosomal rearrangements are the most common genetic alterations in this gene, which result in creation of multiple fusion genes in tumourigenesis, including ALK (chromosome 2)/EML4 (chromosome 2), ALK/RANBP2 (chromosome 2), ALK/ATIC (chromosome 2), ALK/TFG (chromosome 3), ALK/NPM1 (chromosome 5), ALK/SQSTM1 (chromosome 5), ALK/KIF5B (chromosome 10), ALK/CLTC (chromosome 17), ALK/TPM4 (chromosome 19), and ALK/MSN (chromosome X).[provided by RefSeq, Jan 2011] 
ALK Gene-Disease associations (from GenCC):
- neuroblastoma, susceptibility to, 3Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, ClinGen, Labcorp Genetics (formerly Invitae), Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -6 ACMG points.
BP6
Variant 2-29225449-CTG-C is Benign according to our data. Variant chr2-29225449-CTG-C is described in ClinVar as Likely_benign. ClinVar VariationId is 470819.Status of the report is criteria_provided_single_submitter, 1 stars. 
BS2
High AC in GnomAd4 at 6 AD gene. 
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt | 
|---|---|---|---|---|---|---|---|---|---|---|
| ALK | ENST00000389048.8 | c.3172+10_3172+11delCA | intron_variant | Intron 19 of 28 | 1 | NM_004304.5 | ENSP00000373700.3 | |||
| ALK | ENST00000618119.4 | c.2041+10_2041+11delCA | intron_variant | Intron 18 of 27 | 5 | ENSP00000482733.1 | ||||
| ALK | ENST00000431873.6 | n.337+10_337+11delCA | intron_variant | Intron 3 of 13 | 5 | ENSP00000414027.3 | 
Frequencies
GnomAD3 genomes  0.0000394  AC: 6AN: 152170Hom.:  0  Cov.: 32 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
6
AN: 
152170
Hom.: 
Cov.: 
32
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD2 exomes  AF:  0.00000409  AC: 1AN: 244428 AF XY:  0.00000759   show subpopulations 
GnomAD2 exomes 
 AF: 
AC: 
1
AN: 
244428
 AF XY: 
Gnomad AFR exome 
 AF: 
Gnomad AMR exome 
 AF: 
Gnomad ASJ exome 
 AF: 
Gnomad EAS exome 
 AF: 
Gnomad FIN exome 
 AF: 
Gnomad NFE exome 
 AF: 
Gnomad OTH exome 
 AF: 
GnomAD4 exome  AF:  0.0000103  AC: 15AN: 1456046Hom.:  0   AF XY:  0.0000138  AC XY: 10AN XY: 724126 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
15
AN: 
1456046
Hom.: 
 AF XY: 
AC XY: 
10
AN XY: 
724126
show subpopulations 
African (AFR) 
 AF: 
AC: 
8
AN: 
33378
American (AMR) 
 AF: 
AC: 
0
AN: 
44486
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
25874
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
39562
South Asian (SAS) 
 AF: 
AC: 
0
AN: 
84930
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
53102
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
5668
European-Non Finnish (NFE) 
 AF: 
AC: 
1
AN: 
1108876
Other (OTH) 
 AF: 
AC: 
6
AN: 
60170
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.525 
Heterozygous variant carriers
 0 
 1 
 2 
 2 
 3 
 4 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Variant carriers
 0 
 2 
 4 
 6 
 8 
 10 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome  0.0000394  AC: 6AN: 152170Hom.:  0  Cov.: 32 AF XY:  0.0000673  AC XY: 5AN XY: 74330 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
6
AN: 
152170
Hom.: 
Cov.: 
32
 AF XY: 
AC XY: 
5
AN XY: 
74330
show subpopulations 
African (AFR) 
 AF: 
AC: 
6
AN: 
41448
American (AMR) 
 AF: 
AC: 
0
AN: 
15286
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
3470
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
5174
South Asian (SAS) 
 AF: 
AC: 
0
AN: 
4824
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
10624
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
316
European-Non Finnish (NFE) 
 AF: 
AC: 
0
AN: 
68024
Other (OTH) 
 AF: 
AC: 
0
AN: 
2092
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.483 
Heterozygous variant carriers
 0 
 1 
 1 
 2 
 2 
 3 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Variant carriers
 0 
 2 
 4 
 6 
 8 
 10 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
ClinVar
Significance: Likely benign 
Submissions summary: Benign:1 
Revision: criteria provided, single submitter
LINK: link 
Submissions by phenotype
Neuroblastoma, susceptibility to, 3    Benign:1 
Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.